Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particlesPaul Goepfert, Harriet L. Robinson, David C. Montefiori et al.|Retrovirology|2012Cited by 1